Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study
- 1 September 1987
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 144 (9) , 1148-1153
- https://doi.org/10.1176/ajp.144.9.1148
Abstract
Extrapyramidal side effects are a major limitation in the use of neuroleptics, and tardive dyskinesia is a special public health problem. Accurate clinical diagnosis of extrapyramidal syndromes is necessary for effective management. The authors compared clinicians' recognition of the major extrapyramidal syndromes in 48 psychotic inpatients with independent blind diagnoses by clinical researchers using standardized ratings. The major finding was a high rate of clinical underrecognition of all major extrapyramidal syndromes, especially tardive dyskinesia. The authors discuss the clinical predictors of nonrecognition of extrapyramidal side effects and recommend improved training in their detection.This publication has 12 references indexed in Scilit:
- The Varied Clinical Expressions of DystoniaNeurologic Clinics, 1984
- A DANGER IN MAKING THE DIAGNOSIS OF PARKINSON'S DISEASEThe Lancet, 1982
- Perception of tardive dyskinesia in outpatients receiving maintenance neurolepticsAmerican Journal of Psychiatry, 1982
- LACK OF COMPLAINTS IN SCHIZOPHRENICS WITH TARDIVE DYSKINESIAJournal of Nervous & Mental Disease, 1979
- ETHOPROPAZINE AND BENZTROPINE IN NEUROLEPTIC-INDUCED PARKINSONISM1979
- 'Akinetic Depression' in SchizophreniaArchives of General Psychiatry, 1978
- ECDEU Assessment ManualPublished by American Psychological Association (APA) ,1976
- AkinesiaArchives of General Psychiatry, 1975
- The many faces of AkathisiaComprehensive Psychiatry, 1975
- Why Do Schizophrenic Patients Refuse to Take Their Drugs?Archives of General Psychiatry, 1974